The effects of S(-)-, R(+)-, and racemic bupivacaine on lysophosphatidate-induced priming of human neutrophils

Anesthesia and Analgesia

Volumn 97, Issue 4, 2003, Pages 1053-1058

  Hollmann, Markus W ^b   Kurz, Katrin ^b   Herroeder, Susanne ^b   Struemper, Danja ^b   Hahnenkamp, Klaus ^b   Berkelmans, Noud S ^b   Den Bakker, Christel G ^b   Durieux, Marcel E ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BUPIVACAINE; CYTOCHROME C; LYSOPHOSPHATIDIC ACID; SUPEROXIDE;

ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; INFLAMMATION; ISOMERISM; LOCAL ANESTHESIA; NEUTROPHIL; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VOLTAGE CLAMP; XENOPUS;

EID: 0141569745     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000080157.07960.93     Document Type: Article

References (40)

1. Hollmann MW, Durieux ME. Local anesthetics and the inflammatory response: a new therapeutic indication? Anesthesiology 2000;93:858-75.
2. Fischer LG, Bremer A, Coleman EJ, et al. Local anesthetics attenuate lysophosphatidic acid-induced priming in human neutrophils. Anesth Analg 2001;92:1041-7.
3. Condliffe AM, Kitchen E, Chilvers ER. Neutrophil priming: pathophysiological consequences and underlying mechanisms. Clin Sci 1998;94:461-71.
4. Hollmann MW, Gross A, Jelacin N, Durieux ME. Local anesthetic effects on priming and activation of human neutrophils. Anesthesiology 2001;95:113-22.
5. Morrison SG, Dominguez JJ, Frascarolo P, Reiz S. A comparison of the electrocardiographic cardiotoxic effects of racemic bupivacaine, levobupivacaine, and ropivacaine in anesthetized swine. Anesth Analg 2000;90:1308-14.
6. Finegold H, Mandell G, Ramanathan S. Comparison of ropivacaine 0.1%-fentanyl and bupivacaine 0.125%-fentanyl infusions for epidural labour analgesia. Can J Anaesth 2000;47:740-5.
7. Meister GC, D'Angelo R, Owen M, et al. A comparison of epidural analgesia with 0.125% ropivacaine with fentanyl versus 0.125% bupivacaine with fentanyl during labor. Anesth Analg 2000;90:632-7.
8. Campbell DC, Zwack RM, Crone LA, Yip RW. Ambulatory labor epidural analgesia: bupivacaine versus ropivacaine. Anesth Analg 2000;90:1384-9.
9. Polley LS, Columb MO, Naughton NN, et al. Relative analgesic potencies of ropivacaine and bupivacaine for epidural analgesia in labor: implications for therapeutic indexes. Anesthesiology 1999;90:944-50.
10. Leduc C, Gentili ME, Estebe JP, et al. The effect of local anesthetics and amitriptyline on peroxidation in vivo in an inflammatory rat model: preliminary reports. Anesth Analg 2002;95:992-6.
11. Horiguchi T, Shibata MA, Ito Y, et al. Macrophage apoptosis in rat skeletal muscle treated with bupivacaine hydrochloride: possible role of MCP-1. Muscle Nerve 2002;26:79-86.
12. Honemann CW, Heyse TJ, Mollhoff T, et al. The inhibitory effect of bupivacaine on prostaglandin E(2) (EP(1)) receptor functioning: mechanism of action. Anesth Analg 2001;93:628-34.
13. Pongracz J, Lord JM. Superoxide production in human neutrophils: evidence for signal redundancy and the involvement of more than one PKC isoenzyme class. Biochem Biophys Res Commun 1998;247:624-9.
14. Christiansen NO. Pertussis toxin inhibits the FMLP-induced membrane association of protein kinase C in human neutrophils. J Leukoc Biol 1990;47:60-3.
15. Hollmann MW, Fischer LG, Byford AM, Durieux ME. Local anesthetic inhibition of m1 muscarinic acetylcholine signaling. Anesthesiology 2000;93:497-509.
16. Hollmann MW, Ritter CH, Henle P, et al. Inhibition of m3 muscarinic acetylcholine receptors by local anesthetics. Br J Pharmacol 2001;133:207-16.
17. Collinsworth KA, Kalman SM, Harrison DC. The clinical pharmacology of lidocaine as an antiarrhythymic drug. Circulation 1974;50:1217-30.
18. Wiklund L. Human hepatic blood flow and its relation to systemic circulation during intravenous infusion of lidocaine. Acta Anaesthesiol Scand 1977;21:148-60.
19. Tsai PS, Buerkle H, Huang LT, et al. Lidocaine concentrations in plasma and cerebrospinal fluid after systemic bolus administration in humans. Anesth Analg 1998;87:601-4.
20. Mayumi T, Dohi S, Takahashi T. Plasma concentrations of lidocaine associated with cervical, thoracic, and lumbar epidural anesthesia. Anesth Analg 1983;62:578-80.
21. Chan CK, Durieux ME. Effects of halothane and isoflurane on lysophosphatidate signaling. Anesthesiology 1997;86:660-9.
22. - current in Xenopus laevis oocytes. Am J Physiol 1992;263:C896-900.
23. Durieux ME, Lynch KR. Signalling properties of lysophosphatidic acid. Trends Pharmacol Sci 1993;14:249-54.
24. Liliom K, Murakami-Murofushi K, Kobayashi S, et al. Xenopus oocytes express multiple receptors for LPA-like lipid mediators. Am J Physiol 1996;270:C772-7.
25. Fernhout BJH, Dijcks FA, Moolenaar WH, Ruigt GSF. Lysophosphatidic acid induces inward currents in Xenopus laevis oocytes: evidence for an extracellular site of action. Eur J Pharmacol 1992;213:313-5.
26. Kakizawa K, Nomura H, Yoshida A, Ueda H. Signaling of lysophosphatidic acid-evoked chloride current: calcium release from inositol trisphosphate-sensitive store. Brain Res Mol Brain Res 1998;61:232-7.
27. Noh SJ, Kim MJ, Shim S, Han JK. Different signaling pathway between sphingosine-1-phosphate and lysophosphatidic acid in Xenopus oocytes: functional coupling of the sphingosine-1-phosphate receptor to PLC-xbeta in Xenopus oocytes. J Cell Physiol 1998;176:412-23.
28. Guo Z, Liliom K, Fischer DJ, et al. Molecular cloning of a high-affinity receptor for the growth factor-like lipid mediator lysophosphatidic acid from Xenopus oocytes. Proc Natl Acad Sci U S A 1996;93:14367-72.
29. Nietgen GW, Chan CK, Durieux ME. Inhibition of lysophosphatidate signaling by lidocaine and bupivacaine. Anesthesiology 1997;86:1112-9.
30. Nietgen GW, Hoenemann CW, Chan CK, et al. Volatile anaesthetics have differential effects on recombinant m1 and m3 muscarinic acetylcholine receptor function. Br J Anaesth 1998;81:569-77.
31. Durieux ME. Inhibition by ketamine of muscarinic acetylcholine receptor function. Anesth Analg 1995;81:57-62.
32. Durieux ME, Nietgen GW. Synergistic inhibition of muscarinic signaling by ketamine stereoisomers and the preservative benzethonium chloride. Anesthesiology 1997;86:1326-33.
33. Moolenaar WH. Lysophosphatidic acid signalling. Curr Opin Cell Biol 1995;7:203-10.
34. Fourcade O, Simon MF, Viode C, et al. Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells. Cell 1995;80:919-27.
35. Nietgen GW, Durieux ME. Intercellular signaling by lysophosphatidate. Cell Adhes Commun 1998;5:221-35.
36. Krause PJ, Maderazo EG, Bannon P, et al. Neutrophil heterogeneity in patients with blunt trauma. J Lab Clin Med 1988;112:208-15.
37. Chollet-Martin S, Montravers P, Gibert C, et al. Subpopulation of hyperresponsive polymorphonuclear neutrophils in patients with adult respiratory distress syndrome: role of cytokine production. Am Rev Respir Dis 1992;146:990-6.
38. Bass DA, Olbrantz P, Szejda P, et al. Subpopulations of neutrophils with increased oxidative product formation in blood of patients with infection. J Immunol 1986;136:860-6.
39. Smedly LA, Tonnesen MG, Sandhaus RA, et al. Neutrophil-mediated injury to endothelial cells: enhancement by endotoxin and essential role of neutrophil elastase. J Clin Invest 1986;77:1233-43.
40. Worthen GS, Haslett C, Rees AJ, et al. Neutrophil-mediated pulmonary vascular injury: synergistic effect of trace amounts of lipopolysaccharide and neutrophil stimuli on vascular permeability and neutrophil sequestration in the lung. Am Rev Respir Dis 1987;136:19-28.